E. Zander et al., RELATIONS BETWEEN DIABETIC-RETINOPATHY AND CARDIOVASCULAR NEUROPATHY - A CROSS-SECTIONAL STUDY IN IDDM AND NIDDM PATIENTS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(6), 1997, pp. 319-326
The pathogenetic process of diabetic retinopathy and the role of diffe
rent systemic risk factors in IDDM and NIDDM is not completely underst
ood. The aim of the present cross-sectional clinical study was (1) to
compare the prevalence of systemic risk factors for diabetic retinopat
hy in IDDM and NIDDM patients, (2) to determine relations between thes
e risk factors and the degree of retinopathy and (3) to evaluate the r
elationship between retinopathy and neuropathy. The study included 1,2
18 IDDM and 784 NIDDM patients attending our hospital during 1994. The
mean diabetes duration was 15.4 and 13.2 years, respectively. IDDM pa
tients with proliferative retinopathy were characterized by higher mea
n age of 46.4 +/- 1.08 vs. 21.8 +/- 0.42 years and longer diabetes dur
ation of 30.0 +/- 0.79 vs. 7.7 +/- 0.26 years. Among the NIDDM patient
s, those ones with proliferative retinopathy had the lowest mean age o
f 40.5 +/- 1.42 vs. 49.7 +/- 0.61 years (p < 0.01) at diabetes manifes
tation. There was no statistical difference between mean HbA(1c) conce
ntrations in relation to retinopathy stages. Albumin excretion was inc
reased in both IDDM and NIDDM patients with proliferative retinopathy
(p < 0.01) along with increased BMI of IDDM and increased insulin requ
irement of NIDDM patients (p < 0.01). Multiple regression analysis sho
wed that proliferative retinopathy with the inclusion of non-prolifera
tive retinopathy of IDDM and NIDDM patients was significantly correlat
ed with diabetes duration, albumin excretion, somatic and autonomic ne
uropathy (p < 0.01). In NIDDM patients proliferative retinopathy with
the inclusion of nonproliferative retinopathy was correlated with the
age at diabetes manifestation and with cholesterol levels (p < 0.05).
In IDDM and NIDDM patients proliferative retinopathy was found to be c
orrelated with somatic and autonomic neuropathy, albumin excretion (p
< 0.01) and hypertension (p < 0.05). The importance of the significant
correlation of autonomic neuropathy both with background and prolifer
ative retinopathy in IDDM and NIDDM patients needs to be prospectively
investigated.